The effect of locally applied platelet-rich fibrin on donor sites and recipient sites after split-thickness skin transplantation

ISRCTN ISRCTN01737461
DOI https://doi.org/10.1186/ISRCTN01737461
Secondary identifying numbers (KF) 01286728
Submission date
09/01/2006
Registration date
17/02/2006
Last edited
24/07/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Ms Patricia Danielsen
Scientific

Bispebjerg Hospital
Afdeling K
Bispebjerg Bakke 23
2400 Kobenhavn NV
2400
Denmark

Phone +45 (0)3531 3463
Email patriciadanielsen@yahoo.dk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Scientific title
Study acronymThe Donor Study
Study hypothesisPlatelet-rich fibrin shortens wound healing time and improves aesthetic outcome
Ethics approval(s)Yes, 19/09/2005, ref: (KF)01286728
ConditionChronic leg ulcer
InterventionSplit-thickness skin transplantation
Intervention typeOther
Primary outcome measureEpithelialization on day five and nine post-operatively
Secondary outcome measures1. Clinical appearance
2. Histological evaluation
3. Transepidermal Water Loss (TEWL)
4. Erythema
5. Microbiology
6. Incidence of infection
7. Unwanted side effects
8. Temperature difference between treated patients and control group patients
Overall study start date01/01/2006
Overall study end date01/04/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants20
Participant inclusion criteria1. Patients undergoing surgery for chronic leg ulcer
2. Aged over 18 years
3. Written informed consent, the patient is expected to be able to complete the study
4. Donor site area from 2 x (3 cm x 5 cm) to 2 x (7.6 cm x 15 cm)
Participant exclusion criteria1. Non-Danish speaking
2. Dementia
3. Pregnant or breastfeeding women
4. Patients treated with 10 mg of steroid or more daily
5. Patients that have received thrombocyte-inhibiting medicine less than four days before surgery
6. Patients not suited for general or spinal anaesthesia
7. Patients whose donor site has been used as a donor site before
8. Patients with skin diseases or pathological changes in the skin, including infection
Recruitment start date01/01/2006
Recruitment end date01/04/2007

Locations

Countries of recruitment

  • Denmark

Study participating centre

Bispebjerg Hospital
2400 Kobenhavn NV
2400
Denmark

Sponsor information

Vivolution A/S (Denmark)
Industry

Blokken 45
3460 Birkeroed
3460
Denmark

Phone +45 (0)4581 1962
Email info@vivolution.dk
Website http://www.vivolution.com
ROR logo "ROR" https://ror.org/010knjd35

Funders

Funder type

Industry

Vivolution A/S (Denmark)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2008 Yes No
Results article results 01/05/2013 Yes No